Kembali
KLBF - Kalbe Farma

KLBF - Net profit grew 10.97% yoy in 9M25

28 Oktober 2025

KLBF - Net profit grew 10.97% yoy in 9M25 Kalbe Farma (KLBF) booked a net profit of IDR2.63 tn in 9M25, up 10.97% yoy, supported by solid growth across its key business segments. Revenue rose 7.22% yoy to IDR25.98 tn, driven by higher sales in prescription drugs (+11.03%), health products (+9.45%), and distribution & logistics (+10.41%). The nutrition segment remained weak, declining 2.1% yoy to IDR6.04 tn, prompting management to revise its FY25 revenue growth target to 6–8% from the previous 8–10%. Gross profit reached IDR10.55 tn, while total assets climbed to IDR30.10 tn, reflecting steady balance sheet expansion amid higher short-term liabilities. (Source : Bisnis Indonesia)

Related Research

Healthcare
KLBF - Sustaining growth further, after solid 1H25 results
Andre Suntono 28 Agustus 2025 Lihat Detail
Consumer
KLBF - Performa solid pada kuartal pertama tahun 2022
Winny Rahardja 10 Mei 2022 Lihat Detail
Consumer
KLBF - Terus bertumbuh di kuartal II/2022
Winny Rahardja 05 Agustus 2022 Lihat Detail